drugset / Trial / NCT03847857

Study of Porcine Fibrin Sealant in Preventing Cervical Anastomotic Leakage (PLACE030)

NCT03847857 ↗

Phase 3 Active not recruiting 360 enrolled Sun Yat-sen University
RandomizedParallel-groupOpen-labelTreatment

Summary

The primary objective is to evaluate the efficacy and assess the role of Porcine Fibrin Sealant (Bioseal®) in preventing cervical anastomotic leakage after esophagectomy in the patients with resectable thoracic esophageal cancer and gastroesophageal junction cancer.

Timeline

Start
2019-02-21
Primary completion
2023-07-01
Completion
2025-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Porcine Fibrin Sealant (PFS) Protein / enzyme biologic 2.5 ml —

Indications

No indication recorded.